Anaptysbio (ANAB) EBIAT (2016 - 2025)
Historic EBIAT for Anaptysbio (ANAB) over the last 10 years, with Q3 2025 value amounting to $15.1 million.
- Anaptysbio's EBIAT rose 14600.47% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.6 million, marking a year-over-year increase of 4891.28%. This contributed to the annual value of -$145.2 million for FY2024, which is 1123.83% up from last year.
- According to the latest figures from Q3 2025, Anaptysbio's EBIAT is $15.1 million, which was up 14600.47% from -$38.6 million recorded in Q2 2025.
- Anaptysbio's 5-year EBIAT high stood at $15.1 million for Q3 2025, and its period low was -$46.7 million during Q2 2024.
- In the last 5 years, Anaptysbio's EBIAT had a median value of -$33.5 million in 2022 and averaged -$29.4 million.
- Its EBIAT has fluctuated over the past 5 years, first plummeted by 748834.5% in 2022, then skyrocketed by 14600.47% in 2025.
- Quarter analysis of 5 years shows Anaptysbio's EBIAT stood at -$32.5 million in 2021, then increased by 18.82% to -$26.4 million in 2022, then crashed by 59.81% to -$42.2 million in 2023, then surged by 48.39% to -$21.8 million in 2024, then soared by 169.38% to $15.1 million in 2025.
- Its last three reported values are $15.1 million in Q3 2025, -$38.6 million for Q2 2025, and -$39.3 million during Q1 2025.